Living Kidney Donor
8
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Long-Term Risk of Gout in Living Kidney Donors
Long-term Risk of Cardiovascular Disease in Living Kidney Donors
Fracture Risk in Living Kidney Donors
Hybrid Dissemination Study of A Digital-Analog Intervention to Increase Live Donor Kidney Transplantation
Dietary Sodium Intake and Blood Pressure in Living Kidney Donors
Hydrocelectomies in Male Donors
The Effect of Quadratus Lumborum (QL) Block on the Incidence of Chronic Neuropathic Pain After Retroperitoneal Laparoscopic Donor Nephrectomy: A Study on Neuroinflammation and Neurophysiology
Treg Therapy in Subclinical Inflammation in Kidney Transplantation